Hiperlipidemia familiar combinada, síndrome metabólico y enfermedad cardiovascular
作者： Sergio Martinez-Hervás , José T Real , Antonia Priego , Javier Sanz , Jose M Martín
DOI: 10.1157/13095789
关键词:
摘要: Se estudia la relacion entre sindrome metabolico (SM) e infarto agudo de miocardio (IAM) en hiperlipidemia familiar combinada (HFC). comparan 20 sujetos varones con HFC supervivientes a IAM otras 2 series emparejados por edad indice masa corporal (IMC): individuos que no han presentado y controles sanos. determinaron los lipidos, glucosa insulina plasma presencia SM definido criterios Organizacion Mundial Salud (OMS) National Cholesterol Education Program-Adults Treatment Panel (NCEP-ATP-III). El OMS se encontro 19 IAM, 11 sin 6 (p
revespcardiol.org
unirioja.es
elsevier.com参考文章(22)
Ducimetière P, Richard Jl, Eschwege E, Rosselin Ge, Warnet Jm, Thibult N, Claude, Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Hormone and metabolic research. Supplement series. ,vol. 15, pp. 41- 46 ,(1985)
J J Genest, S S Martin-Munley, J R McNamara, J M Ordovas, J Jenner, R H Myers, S R Silberman, P W Wilson, D N Salem, E J Schaefer, Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. ,vol. 85, pp. 2025- 2033 ,(1992) , 10.1161/01.CIR.85.6.2025
Juan F. Ascaso, Jose T. Real, Angel Merchante, Amparo Rodrigo, Rafael Carmena, Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia Metabolism-clinical and Experimental. ,vol. 49, pp. 1627- 1631 ,(2000) , 10.1053/META.2000.18568
B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.-R. Taskinen, L. Groop, Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome Diabetes Care. ,vol. 24, pp. 683- 689 ,(2001) , 10.2337/DIACARE.24.4.683
C. Heller, H. Coirini, A. De Nicola, The placenta as a glucocorticoid target tissue: exchange assay of (3H)-dexamethasone binding and effect of steroids on receptor content. Hormone and Metabolic Research. ,vol. 15, pp. 41- 45 ,(1983) , 10.1055/S-2007-1018622
Juan F Ascaso, Rosario Lorente, Angel Merchante, José T Real, Antonia Priego, Rafael Carmena, Insulin Resistance in Patients With Familial Combined Hyperlipidemia and Coronary Artery Disease The American Journal of Cardiology. ,vol. 80, pp. 1484- 1487 ,(1997) , 10.1016/S0002-9149(97)00737-6
José A. Gimeno Orna, Luis M. Lou Arnal, Edmundo Molinero Herguedas, Beatriz Boned Julián, Desirée P. Portilla Córdoba, Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2 Revista Espanola De Cardiologia. ,vol. 57, pp. 507- 513 ,(2004) , 10.1016/S0300-8932(04)77141-9
E. Bonora, G. Targher, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, L. Gemma, L. Santi, R. C. Bonadonna, M. Muggeo, The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study Diabetic Medicine. ,vol. 21, pp. 52- 58 ,(2004) , 10.1046/J.1464-5491.2003.01068.X
Juan F. Ascaso, Angel Merchante, Rosario I. Lorente, JoséT. Real, José Martinez-Valls, Rafael Carmena, A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients Metabolism-clinical and Experimental. ,vol. 47, pp. 508- 513 ,(1998) , 10.1016/S0026-0495(98)90232-3
R. W. Stout, Insulin and Atheroma: 20-Yr Perspective Diabetes Care. ,vol. 13, pp. 631- 654 ,(1990) , 10.2337/DIACARE.13.6.631